2176 related articles for article (PubMed ID: 33951640)
1. The Immune Responses against Coronavirus Infections: Friend or Foe?
Vafaeinezhad A; Atashzar MR; Baharlou R
Int Arch Allergy Immunol; 2021; 182(9):863-876. PubMed ID: 33951640
[TBL] [Abstract][Full Text] [Related]
2. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.
Prompetchara E; Ketloy C; Palaga T
Asian Pac J Allergy Immunol; 2020 Mar; 38(1):1-9. PubMed ID: 32105090
[TBL] [Abstract][Full Text] [Related]
3. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
Fung TS; Liu DX
Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
[TBL] [Abstract][Full Text] [Related]
4. Progress and Challenges in the Development of COVID-19 Vaccines and Current Understanding of SARS-CoV-2- Specific Immune Responses.
Kim KD; Hwang I; Ku KB; Lee S; Kim SJ; Kim C
J Microbiol Biotechnol; 2020 Aug; 30(8):1109-1115. PubMed ID: 32627758
[TBL] [Abstract][Full Text] [Related]
5. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
Ansariniya H; Seifati SM; Zaker E; Zare F
Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
[TBL] [Abstract][Full Text] [Related]
7. LY6E impairs coronavirus fusion and confers immune control of viral disease.
Pfaender S; Mar KB; Michailidis E; Kratzel A; Boys IN; V'kovski P; Fan W; Kelly JN; Hirt D; Ebert N; Stalder H; Kleine-Weber H; Hoffmann M; Hoffmann HH; Saeed M; Dijkman R; Steinmann E; Wight-Carter M; McDougal MB; Hanners NW; Pöhlmann S; Gallagher T; Todt D; Zimmer G; Rice CM; Schoggins JW; Thiel V
Nat Microbiol; 2020 Nov; 5(11):1330-1339. PubMed ID: 32704094
[TBL] [Abstract][Full Text] [Related]
8. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
9. The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies.
Molaei S; Dadkhah M; Asghariazar V; Karami C; Safarzadeh E
Int Immunopharmacol; 2021 Mar; 92():107051. PubMed ID: 33429331
[TBL] [Abstract][Full Text] [Related]
10. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
Front Immunol; 2021; 12():656433. PubMed ID: 34122413
[TBL] [Abstract][Full Text] [Related]
12. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus infection: An immunologists' perspective.
De Sanctis JB; García AH; Moreno D; Hajduch M
Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027
[TBL] [Abstract][Full Text] [Related]
14. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
15. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
O'Connell P; Aldhamen YA
Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
[TBL] [Abstract][Full Text] [Related]
16. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
Sariol A; Perlman S
Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
[TBL] [Abstract][Full Text] [Related]
17. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
Noor R
Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccine: A comprehensive status report.
Kaur SP; Gupta V
Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
[TBL] [Abstract][Full Text] [Related]
19. The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.
Wong NA; Saier MH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525632
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
Wei J; Alfajaro MM; DeWeirdt PC; Hanna RE; Lu-Culligan WJ; Cai WL; Strine MS; Zhang SM; Graziano VR; Schmitz CO; Chen JS; Mankowski MC; Filler RB; Ravindra NG; Gasque V; de Miguel FJ; Patil A; Chen H; Oguntuyo KY; Abriola L; Surovtseva YV; Orchard RC; Lee B; Lindenbach BD; Politi K; van Dijk D; Kadoch C; Simon MD; Yan Q; Doench JG; Wilen CB
Cell; 2021 Jan; 184(1):76-91.e13. PubMed ID: 33147444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]